Table 1.
The main patient’s characteristics
| Patients | IgG VCA < 213,4 | IgG VCA > 213,4 | p value |
|---|---|---|---|
| Age | |||
| Mean | 11,16 | 11,22 | 0,911 |
| Sex | |||
| male | 26 | 34 | 0,031 |
| female | 12 | 17 | |
| Histological types | |||
| Hodgkin lymphoma | 10 | 28 | 0,002 |
| Non-Hodgkin lymphoma | 21 | 12 | 0,414 |
| Other solid tumor | 20 | 29 | 2,02 |
| TNM stage or Ann Arbor | |||
| Stage I and II | 13 | 16 | |
| Stage III and IV | 21 | 26 | 1,006 |
| Extra nodal involved sites | |||
| Bowel | 4 | 8 | |
| Spleen | 1 | 2 | |
| Liver | 1 | 4 | |
| Other | 4 | 10 | |
| LDH values | |||
| Elevated – mean | 599,31 | 727,59 | 0,89 |
| Prognostic group | |||
| High risk | 9 | 11 | |
| Intermediary risk | 8 | 13 | 0,278 |
| Low risk | 6 | 10 | |
| IPI score | |||
| Mean | 2,38 | 2,41 | 0,884 |
| Performance status | |||
| Mean | 2,41 | 2 | 0,017 |
| Disease free survival | 32 pts | 46 pts | |
| events | 1 | 7 | 0,083 |